Contract Research Organizations Monitoring Essentials for Sponsors

Instructor: Kevin Denny
Product ID: 706111
Training Level: Basic to Intermediate
  • Duration: 60 Min
This webinar will discuss key components of requirements and expectations for sponsors conducting nonclinical safety studies at Contract Research Organizations (CRO’s). The webinar will also review Sponsor responsibilities for assessing and auditing CRO’s conducting nonclinical studies on their behalf.
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.

Customer Care

Fax: +1-650-362-2367

Email: customercare@complianceonline.com

Read Frequently Asked Questions

Why Should You Attend:

GLP compliance for all regulatory submissions is critical for Nonclinical Study Sponsors. Regulators including FDA and EMA are increasingly focused on assessing the sponsor’s initial evaluation and qualification, oversight and monitoring of the CROs Sponsors utilize to conduct nonclinical safety studies for pharmaceutical submissions. This webinar will review basic principles for pre-study assessments Sponsors should conduct before placing nonclinical GLP studies.

What do regulators expect Study Sponsors to do when conducting GLP studies include the following:

  1. Selection and qualification of the CRO to ensure that the CRO that has been selected meets the requirements of the sponsor
  2. A contractual agreement that makes clear exactly which tasks have been delegated to the CRO
  3. Ongoing study monitoring and oversight of the CRO to confirm throughout the study that the CRO continues to meet the sponsor’s requirements
  4. Review best practices for Sponsor monitoring and oversight for Sponsors conducting GLP and Non-GLP services being provided by a CRO

In this webinar, you will learn valuable basic and in-depth information and guidance for conducting Contract Research Organizations (CRO’s) site qualifications for study placement and assessing laboratories capabilities.

Areas Covered in the Webinar:

  • When to conduct initial GLP site audit?
  • Who should conduct the qualification?
  • Areas to concentrate on during the site visit::
    • Study Director
    • Compliance
    • IACUC
    • Facilities
    • Equipment
    • Standard Operating Procedures
    • Animal Care
    • Reagents and Solutions, Expired Supplies and Materials
    • Test and Control Articles
    • Study Protocol and Study Conduct
    • Data Collection and Data Management
    • Document Control

Who Will Benefit:

  • Senior management of small to mid-size biotech and pharmaceutical companies
  • Quality Assurance personnel for sponsor organization
  • Scientists placing nonclinical GLP regulated studies
  • Toxicology Personnel involved in selection and placement of GLP studies at Contract Research Laboratories

From Pharmaceutical, Chemical, Agrichemical, Food Safety industries

Instructor Profile:
Kevin Denny

Kevin Denny
Pharmaceutical Consultant , KDTox Consulting LLC

An experienced pharmaceutical consultant with over 25 years of experience including 11 years as a Study Director and over 15 years as a Nonclinical Project Leader and Study Monitor with extensive work experience leading nonclinical development teams with a successful track record of planning, designing, contracting, monitoring and reporting toxicology studies. Extensive experience supporting drug discovery research and development to progress drug candidate(s) through all phases of nonclinical development from IND enabling to post approval. Authored or co-authored multiple NDAs, INDs, Investigator Brochures and regulatory responses for submissions. Demonstrated experience planning and implementing nonclinical development strategies for multiple therapeutic areas. A subject Matter Expert for outsourcing and evaluating Contract Research Organizations (CROs) and Developmental and Reproductive Toxicology. Experienced in training and development of core nonclinical toxicology research teams and facilities conducting GLP compliant studies internationally.

Follow us :
The Veterinary Drug Approval Process and FDA Regulatory Oversight
Change Control Best Practices - Avoiding Unintended Consequences of Changes

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading